Parkside Financial Bank & Trust Acadia Pharmaceuticals Inc Transaction History

Parkside Financial Bank & Trust

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 06, 2021	SELL	$19.4 - $27.42 $77 - $109	-4 Closed	0 $0
Q4 2020 Feb 09, 2021	BUY	$41.04 - $56.79 $164 - $227	4 New	4 $0
Q3 2020 Nov 06, 2020	SELL	$36.42 - $57.0 $8,922 - $13,965	-245 Closed	0 $0
Q2 2020 Aug 10, 2020	BUY	$39.26 - $52.73 $9,618 - $12,918	245 New	245 $12,000
Q2 2018 Aug 03, 2018	SELL	$15.07 - $22.34 $1,115 - $1,653	-74 Closed	0 $0
Q4 2017 Feb 05, 2018	SELL	$26.84 - $39.14 $1,395 - $2,035	-52 Reduced 41.27%	74 $2,000
Q3 2017 Oct 27, 2017	BUY	$29.49 - $38.37 $3,715 - $4,834	126	126 $5,000

280

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.65B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Parkside Financial Bank & Trust, based on Form 13F filings with the SEC.

Stay updated on Parkside Financial Bank & Trust with notifications on news.